Get Started

GERN

NASD Geron Corporation
Nov 1, 2026 · 5:46 PM ET EOD Market Closed

$0.8944 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.8944, $0.0437 below the day’s high of $0.9381

YTD change
-32.24%
vs 20-day SMA
-23.36%
vs 200-day SMA
-37.35%

Price ranges

Previous day
$0.8606 $0.9381
open $0.9300 close $0.8944
-$0.0356 (-3.83%)
Today
$0.8606 $0.9381
$0.8944
Past week
$0.8400 $1.1900
from $1.1300 now $0.8944
-$0.2356 (-20.85%)
Past month
$0.8400 $1.2600
from $1.2100 now $0.8944
-$0.3156 (-26.08%)
This year
$0.8400 $2.0100
from $1.3200 now $0.8944
-$0.4256 (-32.24%)

Price & Performance

-0.69 (-43.39%) / 6M

$0.8340$1.13$1.42$1.71May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 87.2% away from all-time highs of $6.9900
  • GERN is down 32% since the beginning of the year
  • GERN is down 28% over the past 12 months
  • GERN is down 26% over the past 1 month
  • 12% of all GERN investors are betting against GERN

GERN reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -25.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.02
Earnings momentum -158.4% Quarterly EPS growth
Quarterly change -158.4%

Valuation

P/E ratio N/A
Enterprise value $583.6M
Beta 0.86

Balance sheet & scale

IncomeN/A
Revenue$204.6M
Cash$302.7M
Debt$251.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $574.6M

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $927.89 +13.33%
IQV IQVIA Holdings Inc $267.33 -2.81%
CRL Charles River Laboratories International, Inc. $359.41 -4.44%
ICLR ICON Plc $211.36 -1.91%
IT Gartner, Inc. $228.79 +1.66%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.